EVOKE PHARMA INC's ticker is EVOK and the CUSIP is 30049G104. A total of 19 filers reported holding EVOKE PHARMA INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $21,000 | -8.7% | 42,121 | 0.0% | 0.00% | – |
| Q4 2021 | $23,000 | -58.2% | 42,121 | 0.0% | 0.00% | – |
| Q3 2021 | $55,000 | -5.2% | 42,121 | 0.0% | 0.00% | – |
| Q2 2021 | $58,000 | -24.7% | 42,121 | 0.0% | 0.00% | – |
| Q1 2021 | $77,000 | -18.9% | 42,121 | +14.6% | 0.00% | – |
| Q4 2020 | $95,000 | -45.7% | 36,768 | -1.2% | 0.00% | – |
| Q3 2020 | $175,000 | +31.6% | 37,227 | -0.6% | 0.00% | – |
| Q2 2020 | $133,000 | +241.0% | 37,438 | +10.1% | 0.00% | – |
| Q1 2020 | $39,000 | -29.1% | 33,997 | 0.0% | 0.00% | – |
| Q4 2019 | $55,000 | +89.7% | 33,997 | 0.0% | 0.00% | – |
| Q3 2019 | $29,000 | +38.1% | 33,997 | 0.0% | 0.00% | – |
| Q2 2019 | $21,000 | -58.8% | 33,997 | 0.0% | 0.00% | – |
| Q1 2019 | $51,000 | -39.3% | 33,997 | 0.0% | 0.00% | – |
| Q4 2018 | $84,000 | -16.8% | 33,997 | 0.0% | 0.00% | – |
| Q3 2018 | $101,000 | +18.8% | 33,997 | 0.0% | 0.00% | – |
| Q2 2018 | $85,000 | +19.7% | 33,997 | 0.0% | 0.00% | – |
| Q1 2018 | $71,000 | +4.4% | 33,997 | +13.8% | 0.00% | – |
| Q4 2017 | $68,000 | -30.6% | 29,880 | +2.3% | 0.00% | – |
| Q3 2017 | $98,000 | +30.7% | 29,214 | 0.0% | 0.00% | – |
| Q2 2017 | $75,000 | -17.6% | 29,214 | 0.0% | 0.00% | – |
| Q1 2017 | $91,000 | – | 29,214 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 242,500 | $1,962,000 | 1.69% |
| SOPHROSYNE CAPITAL LLC | 49,000 | $397,000 | 0.40% |
| LMR Partners LLP | 23,882 | $187,000 | 0.02% |
| GEODE CAPITAL MANAGEMENT, LLC | 10,276 | $80,000 | 0.00% |
| BlackRock Investment Management, LLC | 489 | $4,000 | 0.00% |
| MORGAN STANLEY | 500 | $4,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 84 | $1,000 | 0.00% |
| VANGUARD GROUP INC | 48,394 | $378,000 | 0.00% |
| UBS AG | 727 | $6,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 33,500 | $271,000 | 0.00% |